洁特生物(688026) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 reached ¥98,275,342.97, representing a year-on-year increase of 32.30%[3] - Net profit attributable to shareholders was ¥8,178,548.18, marking a significant increase of 192.97% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥4,238,346.03, up by 142.15% year-on-year[3] - The basic and diluted earnings per share both increased to ¥0.07, reflecting a growth of 216.67%[3] - Net profit for Q1 2024 was ¥8,212,634.21, compared to a net loss of ¥8,741,237.41 in Q1 2023, marking a significant turnaround[24] - Earnings per share for Q1 2024 were ¥0.07, compared to a loss per share of ¥0.06 in Q1 2023[25] - The company reported a gross profit margin of approximately 6.4% for Q1 2024, compared to a negative margin in Q1 2023[24] Cash Flow and Investments - The net cash flow from operating activities was ¥35,304,971.53, showing a slight increase of 7.55%[3] - Cash inflow from operating activities in Q1 2024 totaled ¥144,960,102.81, an increase from ¥113,846,781.35 in Q1 2023[26] - The net cash flow from operating activities for Q1 2024 was $35,304,971.53, an increase from $32,825,677.22 in Q1 2023, reflecting a growth of approximately 4.5%[27] - The total cash outflow from investing activities was $88,945,534.56, down from $114,910,710.57 in the previous year, indicating a reduction of about 22.6%[27] - The net cash flow from investing activities was -$26,370,534.56, an improvement compared to -$44,553,665.62 in Q1 2023, showing a decrease in losses of approximately 40.8%[27] - The cash paid for operating activities was $109,655,131.28, an increase from $81,021,104.13 in Q1 2023, indicating a rise of about 35.4%[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,610,526,209.12, a decrease of 0.95% from the end of the previous year[4] - The company reported a total current asset of CNY 744,426,952.14 as of March 31, 2024, a decrease from CNY 770,947,880.57 at the end of 2023, reflecting a decline of approximately 3.43%[18] - The company's cash and cash equivalents amounted to CNY 520,200,418.65, down from CNY 539,133,692.05, indicating a decrease of about 3.38%[18] - Accounts receivable decreased to CNY 106,027,611.95 from CNY 127,541,590.16, representing a decline of approximately 16.93%[18] - Non-current assets totaled CNY 866,099,256.98, slightly increasing from CNY 855,104,330.04, indicating a growth of about 0.12%[19] - The total liabilities decreased to ¥464,849,301.35 in Q1 2024 from ¥468,464,645.23 in Q1 2023[20] - The total equity attributable to shareholders was ¥1,145,020,880.34 in Q1 2024, down from ¥1,156,965,623.98 in Q1 2023[20] Research and Development - Research and development expenses totaled ¥6,497,446.91, which is a decrease of 5.20% compared to the previous year[4] - The proportion of R&D expenses to operating revenue was 6.61%, down by 2.62 percentage points[4] - Research and development expenses for Q1 2024 were ¥6,497,446.91, slightly down from ¥6,854,150.51 in Q1 2023[23] Shareholding Structure - The company reported a total shareholding of 41,072,020 shares by Yuan Jianhua, representing 29.26% of the total shares[10] - JET (H.K.) BIOSCIENCE CO., LIMITED holds 17,547,293 shares, accounting for 12.50% of the total shares[10] - The company has a total of 1,708,861 shares in its repurchase account, which constitutes 1.22% of the total share capital[12] - The top 10 shareholders include several investment firms, with the largest being Yuan Jianhua and JET (H.K.) BIOSCIENCE CO., LIMITED[11] - The company’s shareholding structure indicates a significant concentration of ownership among the top shareholders[10] - The total number of shares held by the top 10 unrestricted shareholders is 77,000,000 shares[11] Legal Matters - The lawsuit involving Guangzhou Baifeier Air Purification Materials Co., Ltd. against Guojiji Intelligent Technology Co., Ltd. has a disputed amount of 20,311,900 RMB[12] - The court ruled in favor of Guojiji Intelligent, ordering the return of 20,311,900 RMB plus interest of 1,667,889.10 RMB to Baifeier[12] - The company is currently involved in an appeal process regarding the court's decision in the aforementioned lawsuit[12] - The company has fully provided for bad debts related to prepayments to Shandong Darong amounting to CNY 7,533,582.08 and inventory write-downs of CNY 3,208,618.86 for PTFE composite mask non-woven fabric[13] - The company is involved in multiple legal disputes, including a case with Shandong Darong involving CNY 10,866,391.80 and a case with Jinbang Holdings involving CNY 12,199,190[14][16] - The company has recorded a provision for bad debts of CNY 5,381,000 related to the dispute with Shanghai Deyou, with a claim amount of CNY 18,441,691.80[16] Accounting and Reporting - The company did not apply new accounting standards for the first quarter of 2024, maintaining consistency in financial reporting[28] - The impact of exchange rate changes on cash and cash equivalents was -$1,190,911.91, slightly worse than -$1,083,213.40 in Q1 2023[27]